On  April  10,  the  "2023 MAIC  2nd  Microfluidics  Application and Innovation Summit Forum" was successfully held in Wuzhen, Zhejiang Province, hosted by the  Organization Department (talent office) of the CPC Tongxiang Municipal Committee, Tongxiang Science and Technology Association and Wuzhen North American Innovation Center, and organized by Mobidrop Biotechnology (Zhejiang) Co. Leaders of relevant government departments, authoritative industry experts and enterprise representatives  gathered together to share the latest achievements in microfluidics, discuss technology transformation and interpret industry development, bringing a rich feast of ideas to all participants.

During this forum, David Weitz, chief scientist of Mobidrop Biologics, member of the Chinese Academy of Sciences, and professor of Harvard University, hosted an inspection

visit to the headquarters building of Mobidrop Biologics completed in 2022, accompanied by Dr. Roy Pei, Chairman and General Manager of Mobidrop Biologics, Dr. Wenshan Zheng , CTO, and Dr.

Han Liu, COO. Professor David Weitz's trip was the first time to Chinese mainland for academic exchange after the three-year of Covid-19 pandemic ended.

At the welcome ceremony, Dr. Roy Pei, Founder, Chairman and General Manager of  Mobidrop Biologics, expressed his warm welcome to David Weitz, Chief Scientist of Mobidrop Biologics, and his appreciation to the leaders from Jiaxing, Tongxiang and  Wuzhen at all levels and the big names from academia and industry for coming. David Weitz, the chief scientist of Mobidrop Bio, expressed his shock at the development of Mobidrop Bio and wished Mobidrop Bio better and better.

In the academic report session of this forum, Prof. Huanan Wang from Dalian University of Technology made a report on "Chitosan-based bioplastics with enhanced

strength and toughness through insect cuticle-mimicking, bioengineered protein- induced supramolecular interactions" to the leaders and experts attending the    conference.

Prof. Yiwei Li from Huazhong University of Science and Technology presented "A universal approach for multiplex single cell sequencing", also Shared a general method for single-cell sequencing mixed-sample experiments by using "new broad-spectrum tags" to label cells.

Dr. Wenshan Zheng, CTO of Mobidrop, shared the report "MobiNova, High-throughput single-cell analysis platforms", introducing MobiNova's high- throughput single-cell multi-omics solution, which is based on the latest droplet microfluidic single-cell. The technology can realize cross-platform, multi-species single-cell multi-omics sequencing.

The MobiMicrobe microbial single -cell platform, which uses an innovative four -step droplet microfluidic microbial single -cell genome sequencing method, provides a  high-throughput  +  high - resolution  method that can  identify strains, enabling     the resolution of high -quality genomes from microbial communities at the strain level         without loss of resolution or broad species applicability, assisting microbial research enter the single -cell era.

In the subsequent roundtable discussion, Prof. David Weitz from Harvard University, Dr. Xing Yang, CEO of Accunome Bio, Prof. Yiwei Li from Huazhong University of Science and        Technology, Prof. Huanan Wang from Dalian University of Technology, and Dr. Wenshan     Zheng, CTO of Mobidrop Bio, had a fascinating dialogue on

Microfluidics and Single Cell Sequencing Technology for Life Science Development".

In the roundtable discussion themed "Discussion on the industrialization of cutting -edge technology projects", Yulin Shen, Secretary of the Party Group and Chairman of Tongxiang Science and Technology Association, Jin Zhu, Deputy Director of Global Industry Research Center of China Federation of Industrial Economics, Mingming Cao, General Manager of China Science and Technology Shuguang Information Industry (Tongxiang Wuzhen) Co. Ltd. and Roy Pei, Chairman and General Manager of Mobidrop Biotechnology (Zhejiang) Co.

Forum Introduction

The  MAIC  Microfluidics  Application  and  Innovation  Summit  aims  to  provide  a  broad multidisciplinary crossover academic exchange platform for scholars engaged in research on multiple microfluidics applications in biology, chemistry, medicine, fluids, and so on, and to continuously promote microfluidics technology innovation and industrialization development.

About Mobidrop

Founded in Boston, USA and located in Zhejiang, China, MobiDroptech is a group of talented people consisting of international top scientists and executives from multinational medical device companies. We are committed to empowering scientific research and precision medicine with innovative microfluidic and single-cell sequencing technologies. It has become a leader in research+IVD solutions with key technologies such as microfluidics, sequencing, biochemistry, hardware development, and bioconferencing, and has launched a dual technology platform for single-cell sequencing and digital PCR, developing in parallel in multiple fields such as liquid biopsy, companion diagnostics, and life science research.